- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05839067
Supporting Health in Veterans With Heart Failure (CARE-HF)
Supporting Physical & Mental Health in Rural Veterans With Heart Failure (CARE-HF)
Study Overview
Detailed Description
The long-term goal of this research is to support physical and mental health of Veterans with heart failure and enrich rehabilitation and independent living by enhancing disease self-management and coping processes in the home.
Study objectives include: (1) Evaluate the feasibility of recruitment and enrollment processes, attrition, and program acceptability in a sample of Veterans with HF; (2) Evaluate program effectiveness on study outcomes (i.e., self-care, symptoms, depression, anxiety, quality of life, stress, resilience, coping, and healthcare utilization); and (3) examine the sustainability of intervention effect.
This study will be guided by quantitative inquiry and include a single-group, repeated measures design. A sample size of 100 participants is desired based on a power analysis for repeated measures ANOVA with 5 time points, alpha level of .05, a medium effect size (f = 0.25), and 80% power, plus oversampling for potential attrition (20%). Following verbal informed consent via telephone, all participants will complete baseline data collection which will include a Sociodemographic and Clinical Survey, the Interpersonal Support Evaluation List - 12 (ISEL), the Social Problem-Solving Inventory Revised-Short (SPSIRs), the Self-care of Heart Failure Index (SCHFI, v 7.2), the Heart Failure Symptom Survey (HFSS), the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder (GAD) scale, the Minnesota Living with Heart Failure Questionnaire (MLHFQ), the Perceived Stress Scale (PSS), the 5x5 Resilience Scale, the Brief COPE, and a healthcare utilization survey.
All participants will participate in a tailored problem-solving intervention designed to help manage heart failure-related problems experienced in the home over 12 weeks (Weeks 1-4, 6, 8, 10, 12). Follow-up data collection will occur at 3-months (post-intervention) and 6-, 12-, and 18-months. Quantitative data on study variables will be collected using the following self-report surveys: SPSIRs, SCHFI, HFSS, PHQ-9, GAD, MLHFQ, PSS, 5x5 Resilience scale, Brief COPE, and healthcare utilization. All data will be collected by a trained research assistant who will collect study data over the telephone and mark participants answers on a computerized data spreadsheet. Possible treatment effectiveness on heart failure self-care, heart failure symptoms, healthcare utilization, depression, anxiety, quality of life, stress, resilience, coping, and differences among subgroups over the study period will be examined using multilevel modeling.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lucinda J Graven, PhD
- Phone Number: 850-644-5601
- Email: lgraven@fsu.edu
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32608
- Recruiting
- VA Clinic - Gainesville
-
Contact:
- Kimberly Phillips
- Email: Kimberly.Phillips1@va.gov
-
-
Maine
-
Togus, Maine, United States, 04330
- Recruiting
- VA Clinic - Togus
-
Contact:
- November Poulin
- Email: November.Poulin@va.gov
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Recruiting
- VA Clinic - Durham
-
Contact:
- Holly Christman
- Email: Holly.Christman@va.gov
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02908
- Recruiting
- VA Clinic - Providence
-
Contact:
- Jeannie Ursillo
- Email: Jeannie.Ursillo@va.gov
-
Contact:
- Elizabeth Medbury
- Email: Elizabeth.Medbury@va.gov
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 years of age or older
- US Veteran
- Diagnosed with heart failure (reduced or preserved ejection fraction)
- Able to read, speak, and understand English
- Reliable telephone access
Exclusion Criteria:
• History of cognitive dysfunction
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CARE-HF
The problem-solving intervention will be led by a registered nurse.
Participants will receive a program manual containing examples of common HF-related problems experienced by heart failure patients and suggested management strategies, with some strategies tailored to the rural sociocultural context.
The nurse will lead participants in a card sorting task intended to help participants prioritize current HF-related problems and will guide participants in developing management strategies for the highest priority problem(s).
Participants will utilize these strategies until the next session at which time the nurse will guide participants in evaluating the effectiveness of chosen strategies.
The iterative process then begins again.
Participants will receive 7 follow-up telephone sessions with the nurse.
In the intervention, the nurse will focus on problems related to self-care, disease management, mental health, and quality of life, including those specific to the rural population.
|
Participants will be trained to use a 5-step problem-solving process based on the Theory of Social Problem-Solving (TSPS) to manage HF-related problems over 12-weeks.
The core belief of TSPS is effective problem-solving requires a positive problem orientation (i.e., viewing problems as a challenge versus a threat) and elicits rational problem-solving versus avoidance or impulsivity/carelessness.
Problem-solving follows from a positive problem orientation and involves accurate problem identification, generation of appropriate potential solutions, active decision-making, and solution implementation and evaluation.
The goal of this intervention is to move participants toward a positive problem orientation and use of rational problem-solving strategies that support greater physical and mental health.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Failure Self-care
Time Frame: baseline
|
Self-care maintenance, management, and confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 7.0.
Items pertain to treatment adherence and self-monitoring.
Scores are standardized (0-100), with higher scores suggesting better self-care maintenance.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
baseline
|
|
Heart Failure Self-care
Time Frame: 3-months
|
Self-care maintenance, management, and confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 7.0.
Items pertain to treatment adherence and self-monitoring.
Scores are standardized (0-100), with higher scores suggesting better self-care maintenance.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
3-months
|
|
Heart Failure Self-care
Time Frame: 6-months
|
Self-care maintenance, management, and confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 7.0.
Items pertain to treatment adherence and self-monitoring.
Scores are standardized (0-100), with higher scores suggesting better self-care maintenance.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
6-months
|
|
Heart Failure Self-care
Time Frame: 12-months
|
Self-care maintenance, management, and confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 7.0.
Items pertain to treatment adherence and self-monitoring.
Scores are standardized (0-100), with higher scores suggesting better self-care maintenance.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
12-months
|
|
Heart Failure Self-care
Time Frame: 18-months
|
Self-care maintenance, management, and confidence will be self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 7.0.
Items pertain to treatment adherence and self-monitoring.
Scores are standardized (0-100), with higher scores suggesting better self-care maintenance.
Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.
|
18-months
|
|
Heart Failure Symptoms
Time Frame: baseline
|
Symptoms of HF will be assessed using the Heart Failure Symptom Survey (HFSS).
This survey contains 14 symptoms commonly experienced by those with HF.
Participants rate each symptom according to 4 domains (i.e., frequency, severity, interference with physical activity, and interference with enjoyment of life) based upon the last 7 days.
Higher scores indicate more of the respective domain in relation to the particular symptom.
|
baseline
|
|
Heart Failure Symptoms
Time Frame: 3-months
|
Symptoms of HF will be assessed using the Heart Failure Symptom Survey (HFSS).
This survey contains 14 symptoms commonly experienced by those with HF.
Participants rate each symptom according to 4 domains (i.e., frequency, severity, interference with physical activity, and interference with enjoyment of life) based upon the last 7 days.
Higher scores indicate more of the respective domain in relation to the particular symptom.
|
3-months
|
|
Heart Failure Symptoms
Time Frame: 6-months
|
Symptoms of HF will be assessed using the Heart Failure Symptom Survey (HFSS).
This survey contains 14 symptoms commonly experienced by those with HF.
Participants rate each symptom according to 4 domains (i.e., frequency, severity, interference with physical activity, and interference with enjoyment of life) based upon the last 7 days.
Higher scores indicate more of the respective domain in relation to the particular symptom.
|
6-months
|
|
Heart Failure Symptoms
Time Frame: 12-months
|
Symptoms of HF will be assessed using the Heart Failure Symptom Survey (HFSS).
This survey contains 14 symptoms commonly experienced by those with HF.
Participants rate each symptom according to 4 domains (i.e., frequency, severity, interference with physical activity, and interference with enjoyment of life) based upon the last 7 days.
Higher scores indicate more of the respective domain in relation to the particular symptom.
|
12-months
|
|
Heart Failure Symptoms
Time Frame: 18-months
|
Symptoms of HF will be assessed using the Heart Failure Symptom Survey (HFSS).
This survey contains 14 symptoms commonly experienced by those with HF.
Participants rate each symptom according to 4 domains (i.e., frequency, severity, interference with physical activity, and interference with enjoyment of life) based upon the last 7 days.
Higher scores indicate more of the respective domain in relation to the particular symptom.
|
18-months
|
|
Depression
Time Frame: baseline
|
Depression will be measured using the Patient Health Questionnaire-9 (PHQ-9).
A PHQ-9 score total of 0-4 points equals "normal" or minimal depression.
Scoring between 5-9 points indicates mild depression, 10-14 points indicates moderate depression, 15-19 points indicates moderately severe depression, and 20 or more points indicates severe depression.
|
baseline
|
|
Depression
Time Frame: 3-months
|
Depression will be measured using the Patient Health Questionnaire-9 (PHQ-9).
A PHQ-9 score total of 0-4 points equals "normal" or minimal depression.
Scoring between 5-9 points indicates mild depression, 10-14 points indicates moderate depression, 15-19 points indicates moderately severe depression, and 20 or more points indicates severe depression.
|
3-months
|
|
Depression
Time Frame: 6-months
|
Depression will be measured using the Patient Health Questionnaire-9 (PHQ-9).
A PHQ-9 score total of 0-4 points equals "normal" or minimal depression.
Scoring between 5-9 points indicates mild depression, 10-14 points indicates moderate depression, 15-19 points indicates moderately severe depression, and 20 or more points indicates severe depression.
|
6-months
|
|
Depression
Time Frame: 12 months
|
Depression will be measured using the Patient Health Questionnaire-9 (PHQ-9).
A PHQ-9 score total of 0-4 points equals "normal" or minimal depression.
Scoring between 5-9 points indicates mild depression, 10-14 points indicates moderate depression, 15-19 points indicates moderately severe depression, and 20 or more points indicates severe depression.
|
12 months
|
|
Depression
Time Frame: 18 months
|
Depression will be measured using the Patient Health Questionnaire-9 (PHQ-9).
A PHQ-9 score total of 0-4 points equals "normal" or minimal depression.
Scoring between 5-9 points indicates mild depression, 10-14 points indicates moderate depression, 15-19 points indicates moderately severe depression, and 20 or more points indicates severe depression.
|
18 months
|
|
Anxiety
Time Frame: baseline
|
Anxiety will be measured using the Generalized Anxiety Disorder (GAD) scale.
Scores are totaled and indicate the level of anxiety.
Score 0-4: Minimal Anxiety.
Score 5-9: Mild Anxiety.
Score 10-14: Moderate Anxiety.
Score greater than 15: Severe Anxiety.
|
baseline
|
|
Anxiety
Time Frame: 3-months
|
Anxiety will be measured using the Generalized Anxiety Disorder (GAD) scale.
Scores are totaled and indicate the level of anxiety.
Score 0-4: Minimal Anxiety.
Score 5-9: Mild Anxiety.
Score 10-14: Moderate Anxiety.
Score greater than 15: Severe Anxiety.
|
3-months
|
|
Anxiety
Time Frame: 6-months
|
Anxiety will be measured using the Generalized Anxiety Disorder (GAD) scale.
Scores are totaled and indicate the level of anxiety.
Score 0-4: Minimal Anxiety.
Score 5-9: Mild Anxiety.
Score 10-14: Moderate Anxiety.
Score greater than 15: Severe Anxiety.
|
6-months
|
|
Anxiety
Time Frame: 12-months
|
Anxiety will be measured using the Generalized Anxiety Disorder (GAD) scale.
Scores are totaled and indicate the level of anxiety.
Score 0-4: Minimal Anxiety.
Score 5-9: Mild Anxiety.
Score 10-14: Moderate Anxiety.
Score greater than 15: Severe Anxiety.
|
12-months
|
|
Anxiety
Time Frame: 18-months
|
Anxiety will be measured using the Generalized Anxiety Disorder (GAD) scale.
Scores are totaled and indicate the level of anxiety.
Score 0-4: Minimal Anxiety.
Score 5-9: Mild Anxiety.
Score 10-14: Moderate Anxiety.
Score greater than 15: Severe Anxiety.
|
18-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health Related Quality of Life
Time Frame: baseline
|
Quality of life will be measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ).
Each item is scored in a 6-point Likert Scale (0 to 5), thus the total score could range from 0 to 105, with higher scores indicating more significant impairment in health-related quality of life
|
baseline
|
|
Health Related Quality of Life
Time Frame: 3-months
|
Quality of life will be measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ).
Each item is scored in a 6-point Likert Scale (0 to 5), thus the total score could range from 0 to 105, with higher scores indicating more significant impairment in health-related quality of life
|
3-months
|
|
Health Related Quality of Life
Time Frame: 6-months
|
Quality of life will be measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ).
Each item is scored in a 6-point Likert Scale (0 to 5), thus the total score could range from 0 to 105, with higher scores indicating more significant impairment in health-related quality of life
|
6-months
|
|
Health Related Quality of Life
Time Frame: 12-months
|
Quality of life will be measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ).
Each item is scored in a 6-point Likert Scale (0 to 5), thus the total score could range from 0 to 105, with higher scores indicating more significant impairment in health-related quality of life
|
12-months
|
|
Health Related Quality of Life
Time Frame: 18-months
|
Quality of life will be measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ).
Each item is scored in a 6-point Likert Scale (0 to 5), thus the total score could range from 0 to 105, with higher scores indicating more significant impairment in health-related quality of life
|
18-months
|
|
Healthcare Utilization
Time Frame: baseline
|
Healthcare utilization was determined by the frequency of emergency department visits and readmissions for HF and assessed via self-report.
|
baseline
|
|
Healthcare Utilization
Time Frame: 3-months
|
Healthcare utilization was determined by the frequency of emergency department visits and readmissions for HF and assessed via self-report.
|
3-months
|
|
Healthcare Utilization
Time Frame: 6-months
|
Healthcare utilization was determined by the frequency of emergency department visits and readmissions for HF and assessed via self-report.
|
6-months
|
|
Healthcare Utilization
Time Frame: 12-months
|
Healthcare utilization was determined by the frequency of emergency department visits and readmissions for HF and assessed via self-report.
|
12-months
|
|
Healthcare Utilization
Time Frame: 18-months
|
Healthcare utilization was determined by the frequency of emergency department visits and readmissions for HF and assessed via self-report.
|
18-months
|
|
Stress
Time Frame: baseline
|
The Perceived Stress Scale (PSS) will measure perceptions of stress and anger.
Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived.
stress.
Scores ranging from 0-13 would be considered low stress.
Scores ranging from 14-26 would be considered moderate stress.
|
baseline
|
|
Stress
Time Frame: 3-months
|
The Perceived Stress Scale (PSS) will measure perceptions of stress and anger.
Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived.
stress.
Scores ranging from 0-13 would be considered low stress.
Scores ranging from 14-26 would be considered moderate stress
|
3-months
|
|
Stress
Time Frame: 6-months
|
The Perceived Stress Scale (PSS) will measure perceptions of stress and anger.
Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived.
stress.
Scores ranging from 0-13 would be considered low stress.
Scores ranging from 14-26 would be considered moderate stress
|
6-months
|
|
Stress
Time Frame: 12-months
|
The Perceived Stress Scale (PSS) will measure perceptions of stress and anger.
Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived.
stress.
Scores ranging from 0-13 would be considered low stress.
Scores ranging from 14-26 would be considered moderate stress
|
12-months
|
|
Stress
Time Frame: 18-months
|
The Perceived Stress Scale (PSS) will measure perceptions of stress and anger.
Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived.
stress.
Scores ranging from 0-13 would be considered low stress.
Scores ranging from 14-26 would be considered moderate stress
|
18-months
|
|
Resilience
Time Frame: baseline
|
The Five-by-Five Resilience Scale will measure aspects of resilience.
Higher scores indicate more resilience.
|
baseline
|
|
Resilience
Time Frame: 3-months
|
The Five-by-Five Resilience Scale will measure aspects of resilience.
Higher scores indicate more resilience.
|
3-months
|
|
Resilience
Time Frame: 6-months
|
The Five-by-Five Resilience Scale will measure aspects of resilience.
Higher scores indicate more resilience.
|
6-months
|
|
Resilience
Time Frame: 12-months
|
The Five-by-Five Resilience Scale will measure aspects of resilience.
Higher scores indicate more resilience.
|
12-months
|
|
Resilience
Time Frame: 18-months
|
The Five-by-Five Resilience Scale will measure aspects of resilience.
Higher scores indicate more resilience.
|
18-months
|
|
Coping
Time Frame: baseline
|
The Brief COPE will measure the use coping strategies.
Each of the 14 scales is comprised of 2 items; total scores on each scale range from 2 (minimum) to 8 (maximum).
Higher scores indicate increased utilization of that specific coping strategy.
Total scores on each of the scales are calculated by summing the appropriate items for each scale.
|
baseline
|
|
Coping
Time Frame: 3-months
|
The Brief COPE will measure the use coping strategies.
Each of the 14 scales is comprised of 2 items; total scores on each scale range from 2 (minimum) to 8 (maximum).
Higher scores indicate increased utilization of that specific coping strategy.
Total scores on each of the scales are calculated by summing the appropriate items for each scale.
|
3-months
|
|
Coping
Time Frame: 6-months
|
The Brief COPE will measure the use coping strategies.
Each of the 14 scales is comprised of 2 items; total scores on each scale range from 2 (minimum) to 8 (maximum).
Higher scores indicate increased utilization of that specific coping strategy.
Total scores on each of the scales are calculated by summing the appropriate items for each scale.
|
6-months
|
|
Coping
Time Frame: 12-months
|
The Brief COPE will measure the use coping strategies.
Each of the 14 scales is comprised of 2 items; total scores on each scale range from 2 (minimum) to 8 (maximum).
Higher scores indicate increased utilization of that specific coping strategy.
Total scores on each of the scales are calculated by summing the appropriate items for each scale.
|
12-months
|
|
Coping
Time Frame: 18-months
|
The Brief COPE will measure the use coping strategies.
Each of the 14 scales is comprised of 2 items; total scores on each scale range from 2 (minimum) to 8 (maximum).
Higher scores indicate increased utilization of that specific coping strategy.
Total scores on each of the scales are calculated by summing the appropriate items for each scale.
|
18-months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Problem-Solving
Time Frame: baseline
|
Problem-solving was self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style.
In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style.
Higher scores on each sub-scale suggest more of the problem-solving characteristic.
Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
|
baseline
|
|
Problem-Solving
Time Frame: 3-months
|
Problem-solving was self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style.
In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style.
Higher scores on each sub-scale suggest more of the problem-solving characteristic.
Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
|
3-months
|
|
Problem-Solving
Time Frame: 6-months
|
Problem-solving was self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style.
In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style.
Higher scores on each sub-scale suggest more of the problem-solving characteristic.
Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
|
6-months
|
|
Problem-Solving
Time Frame: 12-months
|
Problem-solving was self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style.
In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style.
Higher scores on each sub-scale suggest more of the problem-solving characteristic.
Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
|
12-months
|
|
Problem-Solving
Time Frame: 18-months
|
Problem-solving was self-reported and assessed using the Social Problem-Solving Inventory Revised (SPSIR) which measures problem orientation and problem-solving style.
In addition to a total score, there are 5 sub-scales: positive problem orientation, negative problem orientation, rational problem-solving, impulsivity/carelessness, and avoidance style.
Higher scores on each sub-scale suggest more of the problem-solving characteristic.
Higher total scores suggest more adaptive problem-solving, while lower scores indicate more maladaptive problem-solving.
|
18-months
|
|
Social Support
Time Frame: baseline
|
Social support was self-reported and assessed using the Interpersonal Support and Evaluation List - 12 (ISEL-12) which measures perceived belonging, tangible, and appraisal support.
Scores range from 0-36, with higher scores suggesting a higher perception of available support.
|
baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lucinda J Graven, PhD, Florida State University College of Nursing
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00003764
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Umeå UniversityRegion NorrbottenNot yet recruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureSweden
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicJapan, Netherlands, United States, Moldova, Romania
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
Clinical Trials on Care-HF
-
Population Health Research InstituteMcMaster University; Hamilton Health Sciences CorporationRecruitingHeart FailureCanada, Tunisia
-
Emory UniversityNational Institute of Nursing Research (NINR); Atlanta VA Medical Center; Atlanta...CompletedHeart Failure | Diabetes MellitusUnited States
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting
-
Boston Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Nova Scotia Health AuthorityAstraZeneca; Heart and Stroke Foundation of Canada; Atlantic Health Sciences... and other collaboratorsCompletedHeart FailureCanada
-
National Cancer Centre, SingaporeKhoo Teck Puat Hospital; National Heart Centre SingaporeRecruiting
-
East and North Hertfordshire NHS TrustClinical and Interventional Cardiology, Sassari University Hospital, Sassari...RecruitingHeart FailureUnited Kingdom
-
ImplicityRecruitingHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | CRT and/or ICD | Heart Failure With Reduced Ejection Fraction (HFrEF) | Heart Failure With DecompensationFrance
-
University of Alabama at BirminghamUS Department of Veterans AffairsCompletedHeart FailureUnited States
-
Shanghai Zhongshan HospitalNot yet recruiting